Hollenbeck Brent K, Ye Zajoun, Wong Sandra L, Montie James E, Birkmeyer John D
Michigan Surgical Collaborative for Outcomes Research and Evaluation, University of Michigan, Ann Arbor, Michigan 48109, USA.
Cancer. 2008 Feb 15;112(4):806-12. doi: 10.1002/cncr.23234.
Several studies suggest that patients in whom more lymph nodes are examined have improved survival after radical cystectomy for bladder cancer. Despite growing calls for using lymph node counts as a hospital quality indicator, it has not been established that hospitals that obtain more lymph node have better outcomes.
Using the national Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database (1992-2003), all patients undergoing radical cystectomy for cancer were identified (n = 3603). Hospitals were ranked and sorted into 3 evenly sized groups: low (no patients with >or=10 lymph nodes removed), medium (up to 20% of patients), and high (greater than 20% of patients). Survival rates were assessed for each hospital group, adjusting for potentially confounding patient and hospital characteristics.
On average, low lymph node count hospitals had higher observed mortality rates compared with high lymph node count hospitals (unadjusted hazards ratio [HR], 1.25; 95% confidence interval [95% CI], 1.13-1.39). Low lymph node count hospitals tended to treat patients who were older, had more comorbidity, were of lower socioeconomic status, had higher admission acuity, and had lower procedure volumes. After adjusting for these differences, low lymph node count hospitals tended to have slightly higher mortality (adjusted HR, 1.12; 95% CI, 0.99-1.27), although this finding did not reach statistical significance. Similar findings were evident when other thresholds (lymph node counts >or=5, >or=14, and >or=20) were used.
Hospitals with high lymph node counts tend to have higher survival rates after radical cystectomy for bladder cancer. However, this effect is modest and is explained, in large part, by confounding patient and hospital factors.
多项研究表明,膀胱癌根治性膀胱切除术后检查更多淋巴结的患者生存率更高。尽管越来越多的人呼吁将淋巴结计数作为医院质量指标,但尚未确定获取更多淋巴结的医院是否有更好的治疗结果。
利用国家监测、流行病学和最终结果(SEER)-医疗保险链接数据库(1992 - 2003年),识别所有接受癌症根治性膀胱切除术的患者(n = 3603)。医院被排名并分为3个规模均等的组:低(无切除≥10个淋巴结的患者)、中(至多20%的患者)和高(超过20%的患者)。评估每个医院组的生存率,并对潜在的混杂患者和医院特征进行调整。
平均而言,与高淋巴结计数医院相比,低淋巴结计数医院的观察到的死亡率更高(未调整风险比[HR],1.25;95%置信区间[95%CI],1.13 - 1.39)。低淋巴结计数医院倾向于治疗年龄较大、合并症较多、社会经济地位较低、入院急症程度较高且手术量较少的患者。在对这些差异进行调整后,低淋巴结计数医院的死亡率往往略高(调整后HR,1.12;95%CI,0.99 - 1.27),尽管这一发现未达到统计学显著性。当使用其他阈值(淋巴结计数≥5、≥14和≥20)时,也有类似的发现。
膀胱癌根治性膀胱切除术后,淋巴结计数高的医院往往有更高的生存率。然而,这种影响较小,且在很大程度上是由患者和医院的混杂因素所解释的。